Current Studies | UnityPoint Health - Des Moines
Appointment Icon

UnityPoint Clinic - Express (Jordan Creek)

180 Jordan Creek Parkway, Suite 120
West Des Moines, Iowa 50266

00 Patients
Waiting Now

UnityPoint Clinic - Express (Waukee)

950 E. Hickman Road
Waukee, Iowa 50263

00 Patients
Waiting Now

Urgent Care - Altoona

2720 8th St. SW
Altoona, Iowa 50009

00 Patients
Waiting Now

Urgent Care - Ankeny

3625 N. Ankeny Blvd.
Suite E
Ankeny, Iowa 50023

00 Patients
Waiting Now

Urgent Care - Ingersoll

2103 Ingersoll Ave., Ste. 2
Des Moines, Iowa 50312

00 Patients
Waiting Now

Urgent Care - Lakeview

6000 University Avenue
Suite 101
West Des Moines, Iowa 50266

00 Patients
Waiting Now

Urgent Care - Merle Hay

4020 Merle Hay Road
Suite 100
Des Moines, Iowa 50310

00 Patients
Waiting Now

Urgent Care - Southglen

6520 SE 14th St.
Des Moines, Iowa 50320

00 Patients
Waiting Now

Urgent Care - Urbandale

5200 NW 100th Street
Urbandale, Iowa 50322

00 Patients
Waiting Now

Ovarian Cancer Screening Trial

Early detection of ovarian cancer greatly increases survival rates. This study will explore if the CA-125 level is an accurate detector of early stage ovarian cancer.

If you are a woman and want to considered for the trial here are the requirements:

- 50 to 75 years of age

- at least one year post-menopausal

- have at least one ovary

- are willing to have blood draw for a CA-125 test at least once a year

- are cancer free, or have been cancer/treatment free for at least 12 months

For more information about the Ovarian Cancer Screening Trial please contact the UnityPoint Health-Des Moines Office of Research at 515-241-6727.


FDA Approved Studies

The Office of Research has been involved with a variety of inpatient and outpatient studies since the office was established over 15 years ago. Many of the drugs and devices studied have received FDA approval. Following are a few of the FDA approved drugs/devices studied at UnityPoint Health:

Havrix™, dabigatran, alvimopan, micafungin, cinacalcet, omalizumab, dimethyl fumarate, telavancin, everolimus, methylnaltrexone, RotaTeq™, Endurant Endograft Stent™, Aimovig and the INCRAFT™ AAA Stent Graft System.

All studies help answer important clinical questions and help lead us down the path to improved healthcare for the patients we serve.